“…My first scientific paper focused on the association of adjuvant molecules such as bromocriptine, carbamazepine and cyproheptadine with neuroleptics. Despite possible pharmacological mechanisms, the clinical results were disappointing and we could not show any specific efficacy of those drugs on positive and negative symptoms [1].…”